113 related articles for article (PubMed ID: 8104870)
1. Genome scanning of human breast carcinomas using micro- and minisatellite core probes.
Hovig E; Mullaart E; Børresen AL; Uitterlinden AG; Vijg J
Genomics; 1993 Jul; 17(1):66-75. PubMed ID: 8104870
[TBL] [Abstract][Full Text] [Related]
2. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.
Courjal F; Cuny M; Simony-Lafontaine J; Louason G; Speiser P; Zeillinger R; Rodriguez C; Theillet C
Cancer Res; 1997 Oct; 57(19):4360-7. PubMed ID: 9331099
[TBL] [Abstract][Full Text] [Related]
3. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique.
Huang TH; Laux DE; Hamlin BC; Tran P; Tran H; Lubahn DB
Cancer Res; 1997 Mar; 57(6):1030-4. PubMed ID: 9067264
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability and loss of heterozygosity in breast cancer.
Yee CJ; Roodi N; Verrier CS; Parl FF
Cancer Res; 1994 Apr; 54(7):1641-4. PubMed ID: 8137273
[TBL] [Abstract][Full Text] [Related]
5. Notl-Msell methylation-sensitive amplied fragment length polymorhism for DNA methylation analysis of human cancers.
Yamamoto F; Yamamoto M; Soto JL; Kojima E; Wang EN; Perucho M; Sekiya T; Yamanaka H
Electrophoresis; 2001 Jun; 22(10):1946-56. PubMed ID: 11465493
[TBL] [Abstract][Full Text] [Related]
6. Replication error in human breast cancer: comparison with clinical variables and family history of cancer.
Huiping C; Johannsdottir JT; Arason A; Olafsdottir GH; Eiriksdottir G; Egilsson V; Ingvarsson S
Oncol Rep; 1999; 6(1):117-22. PubMed ID: 9864413
[TBL] [Abstract][Full Text] [Related]
7. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS
Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
[TBL] [Abstract][Full Text] [Related]
8. Luminal B breast tumors are not HER2 positive.
Bhargava R; Dabbs DJ
Breast Cancer Res; 2008; 10(5):404; author reply 405. PubMed ID: 18831725
[No Abstract] [Full Text] [Related]
9. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
[TBL] [Abstract][Full Text] [Related]
10. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
11. Determination of amplification level of the c-erbB-2 proto-oncogene in human breast carcinomas: a comparative study between non-radioactive and radioactive labelling.
Edorh A; Parache RM; N'Sossani B; Bottin MC; Merlin JL; Colosetti P; Guillemin F; Le Faou A; Rihn B
Cell Mol Biol (Noisy-le-grand); 1995 Nov; 41(7):967-73. PubMed ID: 8595375
[TBL] [Abstract][Full Text] [Related]
12. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
Courjal F; Theillet C
Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity and p53 gene mutations in breast cancer.
Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
[TBL] [Abstract][Full Text] [Related]
15. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
[TBL] [Abstract][Full Text] [Related]
16. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
[TBL] [Abstract][Full Text] [Related]
17. Specific H-Ras minisatellite alleles in breast cancer susceptibility.
Gosse-Brun S; Sauvaigo S; Daver A; Page M; Lortholary A; Larra F; Bignon YJ; Bernard-Gallon D
Anticancer Res; 1999; 19(6B):5191-6. PubMed ID: 10697533
[TBL] [Abstract][Full Text] [Related]
18. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning.
Hirotsune S; Hatada I; Komatsubara H; Nagai H; Kuma K; Kobayakawa K; Kawara T; Nakagawara A; Fujii K; Mukai T
Cancer Res; 1992 Jul; 52(13):3642-7. PubMed ID: 1617637
[TBL] [Abstract][Full Text] [Related]
19. Detection of genetic alterations in the human gastric cancer cell lines by two-dimensional analysis of genomic DNA.
Kim YS; Yoo HS; Lee KT; Goh SH; Jung JS; Oh SW; Baba M; Yasuda T; Matsubara K; Nagai H
Int J Oncol; 2000 Aug; 17(2):297-308. PubMed ID: 10891539
[TBL] [Abstract][Full Text] [Related]
20. Genome scanning of breast cancers by two-dimensional DNA typing.
Verwest AM; de Leeuw WJ; Molijn AC; Andersen TI; Börresen AL; Mullaart E; Uitterlinden AG; Vijg J
Br J Cancer; 1994 Jan; 69(1):84-92. PubMed ID: 8286216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
